持续性姿势-知觉性头晕与偏头痛的关联:MDDS与前庭性偏头痛
这项单中心回顾性研究纳入62例持续性姿势-知觉性头晕(MDDS)患者,比较合并前庭性偏头痛(MDDS-VM)与不合并者(MDDS-O)的临床特征。结果显示MDDS-VM患者发病年龄更轻、发作间期视觉诱发和头动诱发头晕更常见、DHI和MIDAS评分更高、因工作辞职比例更高,但偏头痛预防治疗可能改善症状。
要点
- MDDS-VM患者发病年龄更轻(41 vs 52岁),发作间期视觉诱发头晕和头动诱发头晕更常见。
- MDDS-VM患者DHI总分、MIDAS评分及因工作辞职比例均显著高于MDDS-O。
- 文拉法辛为所有组最常用治疗(27.3%),MDDS-VM组抗癫痫药和偏头痛预防性维生素也有助于缓解症状。
核心结论
- MDDS-VM患者在头晕严重程度、工作影响和症状数量方面比MDDS-O更重,但偏头痛预防治疗可能带来较好改善潜力。
研究设计与样本
- 回顾性单中心研究,纳入62例MDDS患者,其中MDDS-O 23例(女性19例),MDDS-VM 39例(女性35例)。
主要发现
- MDDS-VM与MDDS-O相比,发病年龄为41 vs 52岁(P = .005)。
- 发作间期视觉诱发头晕为89.7% vs 30.4%(P < .001),头动诱发头晕为87.2% vs 47.8%(P = .001),其他前庭感觉为59% vs 13%(P < .001),发作间期耳部症状为25.6% vs 0%(P = .008)。
- 发作间期症状数量为4.3 vs 2.3(P < .001),DHI总分为54.9 vs 38.1(P = .005),DHI-P评分为16.1 vs 10(P = .004),DHI-F评分为20.9 vs 15.7(P = .016),MIDAS为4.6 vs 32(P = .002),因工作辞职比例为23.2% vs 5%(P = .016)。
- MT-MDDS与SO-MDDS之间未发现任何显著差异。
- 所有组中最常用治疗为文拉法辛(27.3%);MDDS-VM组中抗癫痫药和偏头痛预防性维生素也有助于缓解症状。
临床怎么用
- 对MDDS患者应评估是否合并前庭性偏头痛,合并者头晕更重且工作影响更大,可考虑偏头痛预防治疗。
局限性
- 本研究为回顾性单中心研究,证据等级为3级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Mal de débarquement syndrome (MDDS) is characterized by a persistent rocking sensation, as though on a boat. It may occur following exposure to passive motion (motion-triggered MDDS [MT-MDDS]), or spontaneously (spontaneous-onset MDDS [SO-MDDS]). This study investigated the characteristics of MDDS patients with vestibular migraine (MDDS-VM) to those without (MDDS-O). STUDY DESIGN: Retrospective review. METHODS: Retrospective, single-center study of 62 patients with MDDS. Clinical characteristics, Dizziness Handicap Inventory (DHI), Migraine Disability Assessment Score (MIDAS), job impact, and optimal treatment(s) were studied. RESULTS: There were 23 MDDS-O (19 women), and 39 MDDS-VM (35 women) patients. Comparisons between MDDS-VM and MDDS-O showed significant differences in age of onset (41 vs. 52 years, P = .005), interictal visually induced dizziness (89.7% vs. 30.4%, P < .001), interictal head motion-induced dizziness (87.2% vs. 47.8%, P = .001), other vestibular sensations (59% vs. 13%, P < .001), interictal aural symptoms (25.6% vs. 0%, P = .008), number of interictal symptoms (4.3 vs. 2.3, P < .001), total DHI score (54.9 vs. 38.1, P = .005), DHI-P (physical domain) score (16.1 vs. 10, P = .004), DHI-F (functional domain) score (20.9 vs. 15.7, P = .016 MIDAS (4.6 vs. 32, P = .002), and job resignations (23.2% vs. 5%, P = .016). On the other hand, between-group comparisons for MT-MDDS and SO-MDDS did not reveal any significant differences whatsoever. For optimal treatment, venlafaxine was the most used (27.3%) in all groups. For MDDS-VM, antiepileptic drugs and migraine preventive vitamins were also useful in relieving symptoms. CONCLUSIONS: MDDS-VM patients appear to be more disabled than MDDS-O, in terms of severity of dizziness, job impact, and number of symptoms, but have good potential for improvement, particularly with migraine prophylactic treatment. LEVEL OF EVIDENCE: 3 Laryngoscope, 131:E1653-E1661, 2021.
引用
- Beh SC, Chiang HS, Sanderson C, et al. The Interconnections of Mal de Débarquement Syndrome and Vestibular Migraine. Laryngoscope. 2020. PMID: 33135784. doi:10.1002/lary.29214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。